Total Payments
$419.95
2021 Payments
$20.29
Companies
9
Transactions
26
Medicare Patients
2,648
Medicare Billing
$207,429
Payment Breakdown by Category
Food & Beverage$372.68 (88.7%)
Education$32.27 (7.7%)
Other$15.00 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $372.68 | 24 | 88.7% |
| Education | $32.27 | 1 | 7.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15.00 | 1 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $113.57 | 6 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $95.09 | 5 | $0 (2020) |
| PFIZER INC. | $78.42 | 5 | $0 (2020) |
| Amarin Pharma Inc. | $55.32 | 3 | $0 (2019) |
| Lilly USA, LLC | $29.95 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $16.12 | 1 | $0 (2019) |
| Zealand Pharma US, Inc. | $12.78 | 1 | $0 (2021) |
| Amgen Inc. | $11.19 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $20.29 | 3 | Zealand Pharma US, Inc. ($12.78) |
| 2020 | $100.48 | 6 | Novo Nordisk Inc ($49.30) |
| 2019 | $252.82 | 15 | PFIZER INC. ($62.38) |
| 2017 | $46.36 | 2 | Novo Nordisk Inc ($32.27) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2021 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: CONTRACEPTIVES | ||||||
| 08/27/2021 | Organon LLC | Nexplanon (Drug) | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: WOMENS HEALTH | ||||||
| 02/25/2021 | Zealand Pharma US, Inc. | V-GO DISPOSABLE INSULIN DELIVERY (Device) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: 1 | ||||||
| 07/30/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Endocrinology | ||||||
| 07/23/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Diabetes | ||||||
| 03/12/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Diabetes | ||||||
| 02/18/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $15.00 | General |
| Category: Endocrinology | ||||||
| 01/30/2020 | PFIZER INC. | LYRICA (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 01/17/2020 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Diabetes | ||||||
| 11/05/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: GASTROINTESTINAL | ||||||
| 10/29/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes | ||||||
| 10/22/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: DIABETES | ||||||
| 10/19/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Hypertriglyceridemia | ||||||
| 09/12/2019 | PFIZER INC. | LYRICA (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 08/15/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: DIABETES | ||||||
| 08/08/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/30/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Hypertriglyceridemia | ||||||
| 06/21/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Hypertriglyceridemia | ||||||
| 05/29/2019 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: Bone Health | ||||||
| 05/02/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes | ||||||
| 04/25/2019 | PFIZER INC. | LYRICA (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 03/28/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: VACCINES | ||||||
| 03/27/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Neuroscience | ||||||
| 02/20/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: DIABETES | ||||||
| 05/18/2017 | Novo Nordisk Inc | Saxenda (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 804 | 1,097 | $183,415 | $70,549 |
| 2022 | 15 | 843 | 1,167 | $146,975 | $68,160 |
| 2021 | 12 | 587 | 832 | $79,994 | $41,457 |
| 2020 | 10 | 414 | 549 | $102,655 | $27,264 |
Total Patients
2,648
Total Services
3,645
Medicare Billing
$207,429
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 176 | 325 | $77,422 | $25,167 | 32.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 130 | 130 | $20,800 | $16,065 | 77.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 112 | 173 | $29,140 | $10,260 | 35.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 33 | 33 | $31,974 | $9,277 | 29.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 40 | 41 | $4,920 | $2,942 | 59.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 21 | $7,042 | $1,992 | 28.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 133 | 174 | $2,958 | $1,454 | 49.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 42 | 42 | $1,806 | $1,241 | 68.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 47 | $1,222 | $1,198 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 52 | 74 | $4,311 | $704.48 | 16.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 24 | $1,560 | $218.92 | 14.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 13 | $260.00 | $28.60 | 11.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 149 | 299 | $56,697 | $23,853 | 42.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 139 | 222 | $26,799 | $12,391 | 46.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 96 | 96 | $15,360 | $12,129 | 79.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 27 | 27 | $20,740 | $7,507 | 36.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 66 | 66 | $7,868 | $4,521 | 57.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 76 | 80 | $2,430 | $2,177 | 89.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,127 | $1,426 | 34.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 42 | 42 | $1,644 | $1,200 | 73.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 18 | 19 | $1,606 | $821.91 | 51.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 17 | 36 | $2,474 | $592.14 | 23.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 122 | 174 | $2,958 | $513.09 | 17.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 31 | 42 | $2,122 | $401.62 | 18.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 16 | 18 | $1,423 | $295.71 | 20.8% |
About Dr. Antony Anderson, MD
Dr. Antony Anderson, MD is a Family Medicine healthcare provider based in Midlothian, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851337992.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Antony Anderson, MD has received a total of $419.95 in payments from pharmaceutical and medical device companies, with $20.29 received in 2021. These payments were reported across 26 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($372.68).
As a Medicare-enrolled provider, Anderson has provided services to 2,648 Medicare beneficiaries, totaling 3,645 services with total Medicare billing of $207,429. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Midlothian, TX
- Active Since 06/20/2006
- Last Updated 07/26/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1851337992
Products in Payments
- Ozempic (Drug) $66.16
- Vascepa (Drug) $55.32
- LYRICA (Drug) $48.48
- TOUJEO (Drug) $46.12
- SOLIQUA 100/33 (Biological) $35.14
- Saxenda (Drug) $32.27
- COLOGUARD (Device) $17.20
- FARXIGA (Drug) $16.12
- EMGALITY (Drug) $15.86
- Tresiba (Drug) $15.14
- TRULICITY (Drug) $14.09
- SOLIQUA 100/33 (Drug) $13.83
- V-GO DISPOSABLE INSULIN DELIVERY (Device) $12.78
- PREVNAR - 13 (Biological) $12.74
- Prolia (Biological) $11.19
- Nexplanon (Drug) $6.08
- NEXPLANON (Drug) $1.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Midlothian
Donald Sanders, M.d, M.D
Family Medicine — Payments: $18,297
Family Medicine $18,297
Joseph Goddard, M.d, M.D
Family Medicine — Payments: $17,178
Family Medicine $17,178
Dr. Joseph Castro, D.o, D.O
Family Medicine — Payments: $14,548
Family Medicine $14,548
William Morrissette, M.d, M.D
Family Medicine — Payments: $13,896
Family Medicine $13,896
Dr. Laura Aisenberg, M.d, M.D
Family Medicine — Payments: $13,402
Family Medicine $13,402
Damian Covington, M. D, M. D
Family Medicine — Payments: $12,759
Family Medicine $12,759